APPENDIX 4C AND ACTIVITY REPORT
KEY HIGHLIGHTS: SEPTEMBER QUARTER 2020 • Cash receipts of $12,015,000 • Operating...
Read MoreCLINUVEL Full Year Results 2020
CLINUVEL REPORTS PROFIT, RENVESTING IN BUSINESS Fourth consecutive annual positive net cash...
Read MoreAppendix 4C – quarterly
CLINUVEL PHARMACEUTICALS LTD today announced its Appendix 4C – Quarterly Cashflow Report...
Read More